Literature DB >> 12531358

Immunity under the skin: potential application for topical delivery of vaccines.

C D Partidos1, A-S Beignon, F Mawas, G Belliard, J-P Briand, S Muller.   

Abstract

With the technological advances in biomedical sciences and the better understanding of how the immune system works, new immunisation strategies and vaccine delivery options, such sprays, patches, and edible formulations have been developed. This has opened up the possibility of administering vaccines without the use of needles and syringes. Already topical immunisation is a reality and it has the potential to make vaccine delivery more equitable, safer, and efficient. Furthermore, it would increase the rate of vaccine compliance and greatly facilitate the successful implementation of worldwide mass vaccination campaigns against infectious diseases. This review gives a brief account of the latest developments of application of candidate vaccine antigens onto bare skin and describes some of our recent observations using peptide and glycoconjugate vaccines as immunogens.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12531358     DOI: 10.1016/s0264-410x(02)00597-2

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  10 in total

1.  Pocketed Microneedles for Drug Delivery to the Skin.

Authors:  Harvinder S Gill; Mark R Prausnitz
Journal:  J Phys Chem Solids       Date:  2008-05       Impact factor: 3.995

2.  Transcutaneous immunization with cytotoxic T-cell peptide epitopes provides effective antitumor immunity in mice.

Authors:  Tsuyoshi Itoh; Esteban Celis
Journal:  J Immunother       Date:  2005 Sep-Oct       Impact factor: 4.456

3.  Reverse hexagonal phase nanodispersion of monoolein and oleic acid for topical delivery of peptides: in vitro and in vivo skin penetration of cyclosporin A.

Authors:  Luciana B Lopes; Denise A Ferreira; Daniel de Paula; M Tereza J Garcia; José A Thomazini; Márcia C A Fantini; M Vitória L B Bentley
Journal:  Pharm Res       Date:  2006-05-25       Impact factor: 4.200

4.  Enhanced skin penetration of P20 phosphopeptide using protein transduction domains.

Authors:  Luciana B Lopes; Elizabeth Furnish; Padmini Komalavilas; Brandon L Seal; Alyssa Panitch; M Vitória L B Bentley; Colleen M Brophy
Journal:  Eur J Pharm Biopharm       Date:  2007-10-05       Impact factor: 5.571

5.  Comparative study of the skin penetration of protein transduction domains and a conjugated peptide.

Authors:  Luciana B Lopes; Colleen M Brophy; Elizabeth Furnish; Charles R Flynn; Olivia Sparks; Padmini Komalavilas; Lokesh Joshi; Alyssa Panitch; M Vitoria L B Bentley
Journal:  Pharm Res       Date:  2005-05-17       Impact factor: 4.200

6.  Transcutaneous immunization with hydrophilic recombinant gp100 protein induces antigen-specific cellular immune response.

Authors:  Galit Eisenberg; Arthur Machlenkin; Shoshana Frankenburg; Adva Mansura; Jacob Pitcovski; Eitan Yefenof; Tamar Peretz; Michal Lotem
Journal:  Cell Immunol       Date:  2010-09-18       Impact factor: 4.868

7.  Influenza immunization with trehalose-stabilized virus-like particle vaccine using microneedles.

Authors:  Yeu-Chun Kim; Fu-Shi Quan; Jae-Min Song; Aswani Vunnava; Dae-Goon Yoo; Kyoung-Mi Park; Richard W Compans; Sang-Moo Kang; Mark R Prausnitz
Journal:  Procedia Vaccinol       Date:  2010

8.  Temperature-induced protein release from water-in-oil-in-water double emulsions.

Authors:  Edith C Rojas; Jennifer A Staton; Vijay T John; Kyriakos D Papadopoulos
Journal:  Langmuir       Date:  2008-06-11       Impact factor: 3.882

9.  Topical Anti-Nuclear Factor-Kappa B Small Interfering RNA with Functional Peptides Containing Sericin-Based Hydrogel for Atopic Dermatitis.

Authors:  Takanori Kanazawa; Yuki Shizawa; Mayu Takeuchi; Kuniko Tamano; Hisako Ibaraki; Yasuo Seta; Yuki Takashima; Hiroaki Okada
Journal:  Pharmaceutics       Date:  2015-09-07       Impact factor: 6.321

10.  Skin dendritic cell targeting via microneedle arrays laden with antigen-encapsulated poly-D,L-lactide-co-glycolide nanoparticles induces efficient antitumor and antiviral immune responses.

Authors:  Marija Zaric; Oksana Lyubomska; Olivier Touzelet; Candice Poux; Sharifah Al-Zahrani; Francois Fay; Leah Wallace; Dorothea Terhorst; Bernard Malissen; Sandrine Henri; Ultan F Power; Christopher J Scott; Ryan F Donnelly; Adrien Kissenpfennig
Journal:  ACS Nano       Date:  2013-02-15       Impact factor: 15.881

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.